Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
393.4 USD | +0.09% | -1.13% | -2.75% |
04:21pm | Vertex Pharmaceuticals Says FDA Granted Rolling Review of Suzetrigine to Treat Acute Pain | MT |
Apr. 17 | UBS Adjusts Vertex Pharmaceuticals Price Target to $466 From $498, Maintains Buy Rating | MT |
Filters
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated